LONG-TERM RESULTS OF EXTERNAL BEAM RADIATION THERAPY IN MEN WITH NEWLY DIAGNOSED PROSTATE CANCER WITH DIFFERENT RISK OF PROGRESSION

LONG-TERM RESULTS OF EXTERNAL BEAM RADIATION THERAPY IN MEN WITH NEWLY DIAGNOSED PROSTATE CANCER WITH DIFFERENT RISK OF PROGRESSION

The goal of the study was to evaluate cancer-specific survival in men with newly diagnosed prostate cancer after external beam radiotherapy. The long-term results of 178 patients treated with 3D-confirmal radiotherapy at N.N. Alexandrov National Cancer Centre of Belarus, Minsk, Belarus in 2005-2008...

Full description

Bibliographic Details
Main Authors: P. D. Demeshko, S. A. Krasny
Format: Article
Language:Russian
Published: State Budget Educational Institute of Higher Professional Education, Rostov State Medical University, Ministry Health of Russian Federation 2015-09-01
Series:Vestnik Urologii
Subjects:
prostate cancer
radiation therapy
cancer-specific survival
Online Access:https://www.urovest.ru/jour/article/view/18
id doaj-0c74ca525792485088e1c2ed7a88c456
record_format Article
spelling doaj-0c74ca525792485088e1c2ed7a88c4562021-07-28T16:20:48ZrusState Budget Educational Institute of Higher Professional Education, Rostov State Medical University, Ministry Health of Russian FederationVestnik Urologii2308-64242015-09-0103425310.21886/2308-6424-2015-0-3-42-5318LONG-TERM RESULTS OF EXTERNAL BEAM RADIATION THERAPY IN MEN WITH NEWLY DIAGNOSED PROSTATE CANCER WITH DIFFERENT RISK OF PROGRESSIONP. D. Demeshko0S. A. Krasny1N.N. Alexandrov National Cancer Centre of Belarus, Minsk, BelarusN.N. Alexandrov National Cancer Centre of Belarus, Minsk, BelarusThe goal of the study was to evaluate cancer-specific survival in men with newly diagnosed prostate cancer after external beam radiotherapy. The long-term results of 178 patients treated with 3D-confirmal radiotherapy at N.N. Alexandrov National Cancer Centre of Belarus, Minsk, Belarus in 2005-2008 were analyzed. According to prostate-specific antigen level, clinical stage and Gleason sum patients were stratified into four groups of progression. 9-years cancerspecific survival in patients with low, intermediate, high and very high risk was 81,3±0,1%, 94,3±0,04%, 63,4±0,1% and 49,1±0,09%, respectively (р < 0,005).https://www.urovest.ru/jour/article/view/18prostate cancerradiation therapycancer-specific survival
collection DOAJ
language Russian
format Article
sources DOAJ
author P. D. Demeshko
S. A. Krasny
spellingShingle P. D. Demeshko
S. A. Krasny
LONG-TERM RESULTS OF EXTERNAL BEAM RADIATION THERAPY IN MEN WITH NEWLY DIAGNOSED PROSTATE CANCER WITH DIFFERENT RISK OF PROGRESSION
Vestnik Urologii
prostate cancer
radiation therapy
cancer-specific survival
author_facet P. D. Demeshko
S. A. Krasny
author_sort P. D. Demeshko
title LONG-TERM RESULTS OF EXTERNAL BEAM RADIATION THERAPY IN MEN WITH NEWLY DIAGNOSED PROSTATE CANCER WITH DIFFERENT RISK OF PROGRESSION
title_short LONG-TERM RESULTS OF EXTERNAL BEAM RADIATION THERAPY IN MEN WITH NEWLY DIAGNOSED PROSTATE CANCER WITH DIFFERENT RISK OF PROGRESSION
title_full LONG-TERM RESULTS OF EXTERNAL BEAM RADIATION THERAPY IN MEN WITH NEWLY DIAGNOSED PROSTATE CANCER WITH DIFFERENT RISK OF PROGRESSION
title_fullStr LONG-TERM RESULTS OF EXTERNAL BEAM RADIATION THERAPY IN MEN WITH NEWLY DIAGNOSED PROSTATE CANCER WITH DIFFERENT RISK OF PROGRESSION
title_full_unstemmed LONG-TERM RESULTS OF EXTERNAL BEAM RADIATION THERAPY IN MEN WITH NEWLY DIAGNOSED PROSTATE CANCER WITH DIFFERENT RISK OF PROGRESSION
title_sort long-term results of external beam radiation therapy in men with newly diagnosed prostate cancer with different risk of progression
publisher State Budget Educational Institute of Higher Professional Education, Rostov State Medical University, Ministry Health of Russian Federation
series Vestnik Urologii
issn 2308-6424
publishDate 2015-09-01
description The goal of the study was to evaluate cancer-specific survival in men with newly diagnosed prostate cancer after external beam radiotherapy. The long-term results of 178 patients treated with 3D-confirmal radiotherapy at N.N. Alexandrov National Cancer Centre of Belarus, Minsk, Belarus in 2005-2008 were analyzed. According to prostate-specific antigen level, clinical stage and Gleason sum patients were stratified into four groups of progression. 9-years cancerspecific survival in patients with low, intermediate, high and very high risk was 81,3±0,1%, 94,3±0,04%, 63,4±0,1% and 49,1±0,09%, respectively (р < 0,005).
topic prostate cancer
radiation therapy
cancer-specific survival
url https://www.urovest.ru/jour/article/view/18
work_keys_str_mv AT pddemeshko longtermresultsofexternalbeamradiationtherapyinmenwithnewlydiagnosedprostatecancerwithdifferentriskofprogression
AT sakrasny longtermresultsofexternalbeamradiationtherapyinmenwithnewlydiagnosedprostatecancerwithdifferentriskofprogression
_version_ 1721267475440467968

Similar Items